Literature DB >> 20538141

Management implications of massive left ventricular hypertrophy in hypertrophic cardiomyopathy significantly underestimated by echocardiography but identified by cardiovascular magnetic resonance.

Martin S Maron1, John R Lesser, Barry J Maron.   

Abstract

Cardiovascular magnetic resonance (CMR) is a high spatial resolution, 3-dimensional tomographic imaging technique which may identify regions of massive left ventricular hypertrophy (particularly when confined to the anterolateral free wall) in which the extent of wall thickness is underestimated with traditional 2-dimensional echocardiography in patients with hypertrophic cardiomyopathy (HC). This observation may have potential implications on management strategies as extreme left ventricular hypertrophy is a primary risk factor for sudden death in HC and therefore supports an expanding role for CMR in the evaluation of HC patients.

Entities:  

Mesh:

Year:  2010        PMID: 20538141     DOI: 10.1016/j.amjcard.2010.01.367

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  10 in total

1.  Clinical value of cardiovascular magnetic resonance in patients with MR-conditional pacemakers.

Authors:  Claire E Raphael; Vassilis Vassiliou; Francisco Alpendurada; Sanjay K Prasad; Dudley J Pennell; Raad H Mohiaddin
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2015-11-20       Impact factor: 6.875

2.  Evaluation of apical pouches in hypertrophic cardiomyopathy using cardiac MRI.

Authors:  Kalie Y Kebed; Raed I Al Adham; Kalkidan Bishu; J Wells Askew; Kyle W Klarich; Jae K Oh; Paul R Julsrud; Thomas A Foley; James F Glockner; Rick A Nishimura; Steve R Ommen; Nandan S Anavekar
Journal:  Int J Cardiovasc Imaging       Date:  2014-01-05       Impact factor: 2.357

Review 3.  Clinical utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathy.

Authors:  Martin S Maron
Journal:  J Cardiovasc Magn Reson       Date:  2012-02-01       Impact factor: 5.364

Review 4.  Diagnosis and management of hypertrophic cardiomyopathy.

Authors:  Antonis Pantazis; Annina S Vischer; Maria Carrillo Perez-Tome; Silvia Castelletti
Journal:  Echo Res Pract       Date:  2015-03-11

Review 5.  2014 Korean guidelines for appropriate utilization of cardiovascular magnetic resonance imaging: a joint report of the Korean Society of Cardiology and the Korean Society of Radiology.

Authors:  Yeonyee E Yoon; Yoo Jin Hong; Hyung-Kwan Kim; Jeong A Kim; Jin Oh Na; Dong Hyun Yang; Young Jin Kim; Eui-Young Choi
Journal:  Korean J Radiol       Date:  2014-11-07       Impact factor: 3.500

Review 6.  2014 korean guidelines for appropriate utilization of cardiovascular magnetic resonance imaging: a joint report of the korean society of cardiology and the korean society of radiology.

Authors:  Yeonyee E Yoon; Yoo Jin Hong; Hyung-Kwan Kim; Jeong A Kim; Jin Oh Na; Dong Hyun Yang; Young Jin Kim; Eui-Young Choi
Journal:  Korean Circ J       Date:  2014-11-25       Impact factor: 3.243

Review 7.  Percutaneous Septal Ablation in Hypertrophic Obstructive Cardiomyopathy: From Experiment to Standard of Care.

Authors:  Lothar Faber
Journal:  Adv Med       Date:  2014-05-06

Review 8.  Recent advances in hypertrophic cardiomyopathy.

Authors:  Teerapat Yingchoncharoen; Wh Wilson Tang
Journal:  F1000Prime Rep       Date:  2014-02-03

9.  Left Ventricular Wall Stress Is Sensitive Marker of Hypertrophic Cardiomyopathy With Preserved Ejection Fraction.

Authors:  Xiaodan Zhao; Ru-San Tan; Hak-Chiaw Tang; Soo-Kng Teo; Yi Su; Min Wan; Shuang Leng; Jun-Mei Zhang; John Allen; Ghassan S Kassab; Liang Zhong
Journal:  Front Physiol       Date:  2018-03-28       Impact factor: 4.566

10.  Bizarre ST elevation.

Authors:  Özgür Yaşar Akbal; Berhan Keskin; Aykun Hakgör; Ali Karagöz
Journal:  Anatol J Cardiol       Date:  2018-10       Impact factor: 1.596

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.